Literature DB >> 24595522

Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods.

P Watson1, L Preston, H Squires, J Chilcott, A Brennan.   

Abstract

Our objective was to review modelling methods for type 2 diabetes mellitus prevention cost-effectiveness studies. The review was conducted to inform the design of a policy analysis model capable of assisting resource allocation decisions across a spectrum of prevention strategies. We identified recent systematic reviews of economic evaluations in diabetes prevention and management of obesity. We extracted studies from two existing systematic reviews of economic evaluations for the prevention of diabetes. We extracted studies evaluating interventions in a non-diabetic population with type 2 diabetes as a modelled outcome, from two systematic reviews of obesity intervention economic evaluations. Databases were searched for studies published between 2008 and 2013. For each study, we reviewed details of the model type, structure, and methods for predicting diabetes and cardiovascular disease. Our review identified 46 articles and found variation in modelling approaches for cost-effectiveness evaluations for the prevention of type 2 diabetes. Investigation of the variables used to estimate the risk of type 2 diabetes suggested that impaired glucose regulation, and body mass index were used as the primary risk factors for type 2 diabetes. A minority of cost-effectiveness models for diabetes prevention accounted for the multivariate impacts of interventions on risk factors for type 2 diabetes. Twenty-eight cost-effectiveness models included cardiovascular events in addition to type 2 diabetes. Few cost-effectiveness models have flexibility to evaluate different intervention types. We conclude that to compare a range of prevention interventions it is necessary to incorporate multiple risk factors for diabetes, diabetes-related complications and obesity-related co-morbidity outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24595522     DOI: 10.1007/s40258-014-0091-z

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  7 in total

1.  Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained.

Authors:  Natalia Olchanski; David van Klaveren; Joshua T Cohen; John B Wong; Robin Ruthazer; David M Kent
Journal:  Acta Diabetol       Date:  2021-01-30       Impact factor: 4.280

2.  Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK.

Authors:  P R Breeze; C Thomas; H Squires; A Brennan; C Greaves; P Diggle; E Brunner; A Tabak; L Preston; J Chilcott
Journal:  Diabet Med       Date:  2017-04-18       Impact factor: 4.359

Review 3.  A review of simulation models for the long-term management of type 2 diabetes in low-and-middle income countries.

Authors:  Elton Mukonda; Susan Cleary; Maia Lesosky
Journal:  BMC Health Serv Res       Date:  2021-12-06       Impact factor: 2.655

4.  Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.

Authors:  Carlos K H Wong; Fang-Fang Jiao; Shing-Chung Siu; Colman S C Fung; Daniel Y T Fong; Ka-Wai Wong; Esther Y T Yu; Yvonne Y C Lo; Cindy L K Lam
Journal:  J Diabetes Res       Date:  2015-12-21       Impact factor: 4.011

5.  A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.

Authors:  P Breeze; H Squires; J Chilcott; C Stride; P J Diggle; E Brunner; A Tabak; A Brennan
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

6.  Computer simulation models of pre-diabetes populations: a systematic review protocol.

Authors:  Jose Leal; Waqar Khurshid; Eva Pagano; Talitha Feenstra
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

7.  The Impact of Including Costs and Outcomes of Dementia in a Health Economic Model to Evaluate Lifestyle Interventions to Prevent Diabetes and Cardiovascular Disease.

Authors:  Penny Breeze; Chloe Thomas; Praveen Thokala; Louise Lafortune; Carol Brayne; Alan Brennan
Journal:  Med Decis Making       Date:  2020-09-19       Impact factor: 2.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.